Phreesia (NYSE:PHR) Insider Sells $14,861.64 in Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 1,371 shares of Phreesia stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $10.84, for a total transaction of $14,861.64. Following the sale, the insider owned 23,908 shares in the company, valued at approximately $259,162.72. The trade was a 5.42% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Yvonne Hui also recently made the following trade(s):

• On Friday, April 17th, Yvonne Hui sold 1,327 shares of Phreesia stock. The stock was sold at an average price of $9.28, for a total transaction of $12,314.56.
• On Thursday, April 16th, Yvonne Hui sold 10,063 shares of Phreesia stock. The shares were sold at an average price of $9.08, for a total transaction of $91,372.04.

Phreesia Stock Performance

Shares of NYSE PHR opened at $10.78 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $666.00 million, a P/E ratio of 71.83 and a beta of 0.87. The firm’s fifty day moving average is $9.61 and its two-hundred day moving average is $11.59. Phreesia, Inc. has a 52-week low of $7.77 and a 52-week high of $32.76.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The business had revenue of $130.94 million for the quarter, compared to analysts’ expectations of $130.08 million. During the same quarter in the previous year, the company earned ($0.07) EPS. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. As a group, analysts anticipate that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on PHR. JPMorgan Chase & Co. reissued a “neutral” rating and set a $16.00 price target (down from $24.00) on shares of Phreesia in a research note on Tuesday, March 31st. Mizuho reduced their price objective on Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. Needham & Company LLC decreased their price objective on Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, March 31st. Piper Sandler downgraded Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price for the company. in a research report on Thursday, May 28th. Finally, KeyCorp lowered their target price on Phreesia from $15.00 to $12.00 and set an “overweight” rating for the company in a research report on Monday, April 13th. Nine equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Phreesia has a consensus rating of “Hold” and a consensus target price of $16.65.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC lifted its holdings in Phreesia by 1,119.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after buying an additional 3,001 shares in the last quarter. Van ECK Associates Corp boosted its position in Phreesia by 78.7% in the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after buying an additional 1,102 shares during the period. New York State Teachers Retirement System bought a new position in Phreesia in the 1st quarter worth about $44,000. Rockefeller Capital Management L.P. grew its stake in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after acquiring an additional 2,149 shares in the last quarter. Finally, KBC Group NV increased its position in shares of Phreesia by 83.4% during the fourth quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after acquiring an additional 1,568 shares during the period. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.